Overview
Eric Rugiu-Santoni practices in Copenhagen, Denmark. Mr. Rugiu-Santoni is rated as an Experienced expert by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Thymectomy.
His clinical research consists of co-authoring 74 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Fibrolamellar Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Rugiu-Santoni isDistinguished. Learn about Lung Cancer.
- Advanced
- MesotheliomaMr. Rugiu-Santoni isAdvanced. Learn about Mesothelioma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Rugiu-Santoni isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- Breast CancerMr. Rugiu-Santoni isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerMr. Rugiu-Santoni isExperienced. Learn about EGFR Positive Lung Cancer.
- Fibrolamellar CarcinomaMr. Rugiu-Santoni isExperienced. Learn about Fibrolamellar Carcinoma.
- HydroceleMr. Rugiu-Santoni isExperienced. Learn about Hydrocele.
- NeuroblastomaMr. Rugiu-Santoni isExperienced. Learn about Neuroblastoma.
- Opsoclonus-Myoclonus SyndromeMr. Rugiu-Santoni isExperienced. Learn about Opsoclonus-Myoclonus Syndrome.